Acacetin also exhibits a protective effect on diabetes-induced endothelial cell injury [132], cardiomyopathy [83], and kidney disease [133] by targeting PPARα, the Sirt1/Sirt3 signaling pathway, and dipeptidyl peptidase-4 (DPP4). This evidence concerns the gene DPP4 and cardiomyopathy.